| Literature DB >> 35056744 |
Ming-Der Wu1, Wen-Wei Lin2, Ming-Jen Cheng1, Jih-Jung Chen3,4, Nanthaphong Khamthong5, Yueh-Hsiung Kuo6,7,8.
Abstract
Seven new compounds, including one dimer novel skeleton, chamaecyformosanin A (1); three diterpenes, chamaecyformosanins B-D (2-4); one sesquiterpene, chamaecyformosanin E (5); and two monoterpenes, chamaecyformosanins F and G (6 and 7) were isolated from the methanol extract of the bark of Chamaecyparis obtusa var. formosana. Their structures were established by the mean of spectroscopic analysis and the comparison of NMR data with those of known analogues. Their structures were elucidated on the basis of physicochemical evidence, in-depth NMR spectroscopic analysis, and high-resolution mass spectrometry. Furthermore, the isolated compounds were subjected to an evaluation of their antimicrobial activity. Metabolites 1, 3, and 4 present antibacterial activities. It is worth mentioning that the chemical composition of the bark of C. obtusa var. formosana has never been studied in the past. This is the first time the barks from C. obtusa var. formosana were studied and two new skeleton compounds, 1 and 7, were obtained.Entities:
Keywords: Chamaecyparis obtusa var. formosana; Cupressaceae; antimicrobial activities; dimer; diterpenoid; novel skeleton; traditional herbal medicine
Mesh:
Substances:
Year: 2022 PMID: 35056744 PMCID: PMC8779593 DOI: 10.3390/molecules27020429
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Compounds 1–7, isolated from Chamaecyparis obtusa var. formosana.
Figure 2Key COSY (▬) and HMBC (→) correlations of 1–7.
Figure 3Major NOESY (↔) contacts of 1–7.
13C-NMR Data for Compounds 1–7 (δ in ppm, 125 MHz for 13C NMR in CDCl3).
| No | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 36.9 | 34.6 | 40.9 | 41.0 | 39.0 | 91.9 | 44.5 |
| 2 | 27.4 | 18.7 | 19.6 | 19.5 | 19.9 | 84.6 | 39.3 |
| 3 | 78.7 | 37.5 | 38.0 | 38.0 | 37.9 | 44.5 | 20.1 |
| 4 | 39.8 | 35.4 | 44.1 | 44.0 | 44.1 | 42.0 | 37.1 |
| 5 | 52.8 | 53.2 | 55.6 | 55.3 | 56.2 | 35.7 | 43.9 |
| 6 | 84.0 | 19.9 | 24.9 | 24.8 | 26.0 | 170.3 | 57.9 |
| 7 | 46.2 | 25.6 | 37.2 | 37.0 | 38.6 | 38.0 | 22.8 |
| 8 | 127.6 | 159.5 | 148.9 | 148.2 | 148.3 | 24.6 | 21.7 |
| 9 | 147.0 | 134.4 | 60.6 | 60.8 | 52.4 | 26.4 | 55.9 |
| 10 | 36.9 | 43.4 | 40.0 | 40.4 | 40.2 | 20.3 | 184.3 |
| 11 | 109.3 | 172.3 | 136.2 | 139.2 | 28.7 | 27.9 | |
| 12 | 151.5 | 70.6 | 136.1 | 124.2 | 77.3 | 12.4 | |
| 13 | 131.2 | 28.7 | 154.8 | 161.7 | 142.4 | 180.2 | |
| 14 | 125.7 | 183.4 | 117.5 | 114.6 | 121.8 | ||
| 15 | 26.3 | 17.6 | 172.6 | 174.0 | 60.9 | ||
| 16 | 22.0 | 14.3 | 70.5 | 10.7 | |||
| 17 | 22.2 | 108.4 | 108.7 | 106.9 | |||
| 18 | 28.3 | 28.9 | 28.9 | 28.9 | |||
| 19 | 20.9 | 183.9 | 182.3 | 183.0 | |||
| 20 | 16.2 | 13.7 | 13.7 | 12.9 | |||
| 1′ | 130.2 | ||||||
| 2′ | 118.5 | ||||||
| 3′ | 157.3 | ||||||
| 4′ | 132.0 | ||||||
| 5′ | 126.6 | ||||||
| 6′ | 129.8 | ||||||
| 7′ | 127.4 | ||||||
| 8′ | 126.2 | ||||||
| 9′ | 134.0 | ||||||
| 10′ | 132.3 | ||||||
| 11′ | 24.0 | ||||||
| 12′ | 41.1 | ||||||
| 13′ | 214.1 | ||||||
| 14′ | 41.0 | ||||||
| 15′ | 18.4 | ||||||
| 16 | 18.0 | ||||||
| 17′ | 20.6 | ||||||
| 18′ | 28.6 | ||||||
| 19′ | 21.3 | ||||||
| 20′ | 22.6 |
1H-NMR Data for Compounds 1–7 in CDCl3 (δ in ppm, J in Hz, 500 MHz in CDCl3).
| No | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| 1 | 1.78 (m) | 1.16 (dd, | 1.07 (m) | 1.09 (m) | 0.95 (m) | ||
| 2.17 (m) | 2.56 (d, | 1.46 (m) | 1.44 (m) | 1.79 (m) | |||
| 2 | 1.89 (m) | 1.53 (m, H-2α) | 1.46 (m) | 1.76 (m) | 1.50 (m) | 3.62 (d, | 1.20 (m, H-2α(ax)) |
| 1.91 (m) | 1.88 (td, | 1.85 (m) | 1.83 (m) | 1.83 (m) | 2.10 (d, J = 13.0, H-2β(equ)) | ||
| 3 | 3.39 (dd, | 1.08 (dd, | 1.05 (m) | 1.06(m) | 1.03 (m) | 1.52 (m) | |
| 2.22 (m) | 2.18 (br d, J = 12.3) | 2.18(m) | 2.13 (m) | 1.82 (m) | |||
| 4 | 1.95 (td, | 0.91 (td, J = 13.5, 4.3, H-4α(equ)) | |||||
| 2.17(m, H-4α(ax)) | |||||||
| 5 | 1.74 (d, | 1.40 (dd, | 1.33 (dd, | 1.33 (dd, | 1.27 (m) | 2.47 (dd, | |
| 2.71 (dt, | |||||||
| 6 | 5.21 (t, | 1.95 (m) | 1.90 (m) | 1.89 (m) | 1.83 (m) | 1.40 (dd, | |
| 2.17 (m) | 1.98 (m) | 1.99 (m) | 1.94 (m) | ||||
| 7 | 4.74 (d, | 2.26 (m) | 2.00 (m) | 2.01 (m) | 1.82 (m) | 1.68 (dd, | 1.83 (m) |
| 2.37 (m) | 2.45 (m) | 2.46 (m) | 2.38 (m) | 2.12 (ddd, | 2.18 (m) | ||
| 8 | 1.04 (s) | 1.72 (m) | |||||
| 2.09 (m) | |||||||
| 9 | 2.43 (m) | 2.47 (m) | 1.42 (m) | 1.15 (s) | 2.38 (t, | ||
| 10 | 1.42 (s) | ||||||
| 11 | 6.91 (s) | 6.21 (dd, | 6.13 (dd, | 1.27 (m) | 1.21 (s) | ||
| 1.68 (m) | |||||||
| 12 | 4.54 (d, | 6.09 (d, | 6.37 (d, | 4.12 (dd, | 0.62 (s) | ||
| 4.59 (d, | |||||||
| 13 | 1.28 (s) | ||||||
| 14 | 6.48 (s) | 5.71 (s) | 5.85 ( | 5.40 (t, | |||
| 15 | 2.87 (sept, | 1.04 (s) | 4.60 (dd, | ||||
| 16 | 0.84 (d, | 2.29 (s) | 4.97 (br s) | 1.67 (s) | |||
| 17 | 0.67 (d, | 4.41 (br s) | 4.66 (br s) | ||||
| 4.76 (br s) | 4.87 (br s) | ||||||
| 18 | 1.26 (s) | 1.25 (s) | 1.21 (s) | ||||
| 19 | 1.14 (s) | ||||||
| 20 | 1.28 (s) | 0.76 (s) | 0.59 (s) | ||||
| 21 | |||||||
| 22 | 2.04 (s) | ||||||
| 1′ | |||||||
| 2′ | |||||||
| 3′ | |||||||
| 4′ | |||||||
| 5′ | 7.49 (s) | ||||||
| 6′ | |||||||
| 7′ | 7.58 (d, | ||||||
| 8′ | 7.13 (d, | ||||||
| 9′ | |||||||
| 10′ | |||||||
| 11′ | 3.10 (m),3.33 (m) | ||||||
| 12′ | 2.64 (m), 2.68 (m) | ||||||
| 13′ | |||||||
| 14′ | 2.49 (sept, | ||||||
| 15′ | 0.99 (d, | ||||||
| 16′ | 1.01 (d, | ||||||
| 17′ | 2.46 (s) | ||||||
| 18′ | 3.09 (sept, | ||||||
| 19′ | 1.25 (d, | ||||||
| 20′ | 1.27 (d, |
Antimicrobial activities of five sufficient compounds isolated from the bark of C. obtusa var. formosana (diameter of the zone of growth inhibition, bactericidal or fungicidal zone in mm, including the diameter of the disc, 8 mm).
| Test Microorganism | Isolated Compounds | Tetracycline | Ketoconazole | ||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |||
| 24 | – | 30 | 27 | – | 25 | – | |
| 25 | – | 29 | 29 | – | 24 | – | |
|
| 22 | – | 28 | 29 | – | 24 | – |
|
| 21 | – | 29 | 28 | – | 23 | – |
| 12 | – | 17 | 19 | – | – | 32 | |
|
| 13 | – | 20 | 16 | – | – | 30 |
| 20 | – | 19 | 19 | – | – | 29 | |
| 19 | – | 17 | 17 | – | – | 32 | |
Inhibition zone diameter (mm); – = no inhibition zone; positive controls: tetracycline and ketoconazole.